Table 1.
All-oral direct acting antiviral regimens available for clinical use.
Table 2.
Sustained virologic response for all-oral direct acting antiviral regimens.
Fig 1.
The HCV polyprotein is processed into the structural and nonstructural proteins of the virus, as shown here. The NS3–4A, NS5A, and NS5B proteins, all targets of newly developed direct-acting antivirals for HCV, are highlighted in red and their major functions described.
Table 3.
Properties of HCV direct-acting antivirals.